Castleview Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-28
| Closed | -$3.84K | – | 711 |
|
|
2024
Q2 | $3.84K | Hold |
28
| – | – | ﹤0.01% | 656 |
|
|
2024
Q1 | $3.84K | Hold |
28
| – | – | ﹤0.01% | 671 |
|
|
2023
Q4 | $3.8K | Sell |
28
-1,593
| -98% | -$216K | ﹤0.01% | 616 |
|
|
2023
Q3 | $198K | Sell |
1,621
-33
| -2% | -$4.04K | 0.18% | 114 |
|
|
2023
Q2 | $210K | Buy |
1,654
+605
| +58% | +$76.8K | 0.19% | 108 |
|
|
2023
Q1 | $135K | Buy |
1,049
+1,021
| +3,646% | +$132K | 0.12% | 149 |
|
|
2022
Q4 | $3.68K | Hold |
28
| – | – | ﹤0.01% | 469 |
|
|
2022
Q3 | $3K | Buy |
28
+23
| +460% | +$2.46K | ﹤0.01% | 494 |
|
|
2022
Q2 | $328 | Sell |
5
-23
| -82% | -$1.51K | ﹤0.01% | 732 |
|
|
2022
Q1 | $3K | Sell |
28
-25,306
| -100% | -$2.71M | ﹤0.01% | 613 |
|
|
2021
Q4 | $166 | Buy |
+25,334
| New | +$166 | ﹤0.01% | 715 |
|
|
2021
Q2 | $27K | Buy |
+166
| New | +$27K | 0.01% | 511 |
|
|
2018
Q1 | $440K | Buy |
+4,120
| New | +$440K | 0.36% | 62 |
|